drug adverse effects of antiplatelet agents
Jump to navigation
Jump to search
Adverse effects
- increased risk of bleeding
- especially risk of upper GI bleed
- risk of upper GI bleed attenuated if used in combination with proton pump inhibitor
- especially risk of upper GI bleed
- with chronic kidney disease
- lack of clear efficacy in reducing cardiovascular morbidity & mortality
- increased risk of bleeding[2]
More general terms
References
- ↑ Ibanez L, Vidal X, Vendrell L, Moretti U, Laporte JR; Spanish- Italian Collaborative Group for the Epidemiology of Gastrointestinal Bleeding. Upper gastrointestinal bleeding associated with antiplatelet drugs. Aliment Pharmacol Ther. 2006 Jan 15;23(2):235-42. PMID: https://www.ncbi.nlm.nih.gov/pubmed/16393302
- ↑ 2.0 2.1 Palmer SC Effects of Antiplatelet Therapy on Mortality and Cardiovascular and Bleeding Outcomes in Persons With Chronic Kidney Disease: A Systematic Review and Meta-analysis Ann Intern Med March 20, 2012 156:445-459 PMID: https://www.ncbi.nlm.nih.gov/pubmed/22431677